Analytical services are critical to the development and manufacture of safe and effective biopharmaceuticals. These analytical services often are outsourced to third-party laboratories, and in some ca...
Read more
Biologics development is complex. Each project involves multiple stakeholders, tight timelines and strict regulatory standards. For companies working with a Contract Development and Manufacturing Orga...
Read more
Alzheimer’s disease (AD) is one of the most significant and pressing challenges in modern healthcare. Affecting more than 50 million people worldwide1, AD places an immense and growing social and ec...
Read more
53Biologics ha sido distinguida hoy con el Premio Pyme del Año 2025 de Valladolid, un reconocimiento otorgado por Banco Santander y la Cámara de Comercio de Valladolid, en colaboración con la Cáma...
Read more
This article explores the scope of preclinical contract research, best practices in study design, key FDA toxicology guidelines for compliance, and common challenges that impact project efficiency.
Read more
A consortium formed by the Clínica Universidad de Navarra, the Hospital Universitario de Navarra, the University of Navarra, the research centers FIMA and Navarrabiomed, and the technology companies ...
Read more
Joan Puig: “In inorganic growth in Europe, cultural difference is one of the most important challenges”.
Read more
El reclutamiento de pacientes sigue siendo uno de los mayores retos en la ejecución de ensayos clínicos. No es extraño que más del 80% de los estudios se retrasen por dificultades para alcanzar lo...
Read more
The European Health Data Space (EHDS) will transform the way health data are identified, requested, and used in clinical research, pharmacovigilance, health technology assessment, and regulatory activ...
Read more
3PBIOVIAN, a company specialized in the development and manufacturing of biological medicines for third parties, and Universidad CEU San Pablo in Madrid have signed a Business Collaboration Agreement ...
Read more
Advanced therapies, encompassing gene treatments, cell-based therapies, and tissue-engineered products, have marked a turning point in modern medicine. These innovations offer solutions for severe dis...
Read more
The U.S. multinational BioIVT, a global leader in the development of high-quality biological samples and research services for drug and diagnostic development, has acquired the Catalan company BeCytes...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
